Intralytix, Inc. is a biotechnology company focused on the discovery, production and marketing of bacteriophage-based products to control bacterial pathogens in environmental, food processing, and medical settings.
Bacteriophages (bacteria-eater: from the Greek phago meaning "to eat" or "to develop at the expense of") are the most abundant microorganisms on earth. They are the natural enemies of bacteria. Lytic bacteriophages can very effectively kill their targeted specific bacteria without affecting anything else, ensuring an unprecedented level of safety for an antimicrobial.
In The News
Intralytix Receives SBIR Grant to Develop Phage Preparation for Reducing Vibrio parahaemolyticus Contamination of Foods
Intralytix, Inc. announced today that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Food and Agriculture (NIFA), an agency of the U.S. Department of Agriculture (USDA), for the development of a phage biocontrol solution for Vibrio parahaemolyticus in various food products, including seafood.
How bacteriophages can help us shape the microbiome
An interview with Alexander "Sandro" Sulakvelidze, President and CEO of Intralytix, Inc.
Intralytix receives a positive #LuxTake by Lux Research
Intralytix was given a "Positive" Lux Take by Lux Research in its report to its subscribing membership.
Antibiotic-resistant 'superbugs' could be the next big health threat. Beneficial viruses could be the solution
Maryland is a hotspot for research and production of superbug-killing bacteriophages.